1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Transarterial Chemoembolization: new trials by email Literature Review of Transarterial Chemoembolization trials Research Report on Transarterial Chemoembolization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma lenvatinib + sindilimab/carrelizumab, TACE - Hepatocellular Carcinoma Non-resectable, Transarterial Chemoembolization | Phase 1 / Phase 2 | Completed | Xinrui Zhu，MD | 142 | 2020-10-01 | 2025-08-29 |
camrelizumab (1) · lenvatinib (1)
Xinrui Zhu，MD (1)
China (1)